APA (7th ed.) Citation

Inoue, S., Sassa, N., Kato, T., Yamauchi, Y., Hirabayashi, T., Yuguchi, Y., . . . Gotoh, M. (2020). Presence of constipation predicts the therapeutic efficacy of pembrolizumab in metastatic urothelial cancer patients. International Journal of Urology, 27(12), 1116. https://doi.org/10.1111/iju.14367

Chicago Style (17th ed.) Citation

Inoue, Satoshi, et al. "Presence of Constipation Predicts the Therapeutic Efficacy of Pembrolizumab in Metastatic Urothelial Cancer Patients." International Journal of Urology 27, no. 12 (2020): 1116. https://doi.org/10.1111/iju.14367.

MLA (9th ed.) Citation

Inoue, Satoshi, et al. "Presence of Constipation Predicts the Therapeutic Efficacy of Pembrolizumab in Metastatic Urothelial Cancer Patients." International Journal of Urology, vol. 27, no. 12, 2020, p. 1116, https://doi.org/10.1111/iju.14367.